Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
NCT ID: NCT06907563
Last Updated: 2025-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
30000 participants
OBSERVATIONAL
2025-04-15
2035-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The European NAFLD Registry
NCT04442334
Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients
NCT00844779
Sexual Dysfunction in Patients With Chronic Liver Disease
NCT04896723
Characterization and Pathogenesis of ACLF
NCT04975490
Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease
NCT06879236
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
European SLD Registry
The EU-SLD registry comprises patients from 18 european countries and a study cohort of n=8.984 with most recent cases recruited in the prospective LITMUS cohort study. Now followed up as part of the LOVE Study in the EU-LIVERAIM project.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 years of age
* Diagnosis of SLD (MASLD, MetALD, ALD)
Exclusion Criteria
* \< 18 years of age
* No Diagnosis of SLD (MASLD, MetALD, ALD)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitatsmedizin Mainz - 1. Medizinische Klinik
OTHER
Newcastle University
OTHER
Barcelona Institute for Global Health
OTHER
Odense University Hospital
OTHER
Hospital Clinic of Barcelona
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
University of Turin, Italy
OTHER
Universität des Saarlandes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital de la Pitié Salpêtrière
Paris, , France
University Medical Center Saarland, Department of Internal Medicine II
Homburg, Saarland, Germany
Division of Gastroenterology, Department of Medical Sciences, University of Turin
Turin, , Italy
Translational & Clinical Research Institute Faculty of Medical Sciences
Newcastle upon Tyne, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Division of Gastroenterology, Department of Medical Sciences
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LOVE study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.